Dorsal Root Ganglion Stimulation for Hand and Upper Limb Pain
TerminatedNCT02553876
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
There are no studies as yet specifically investigating the application of DRG stimulation in the treatment of chronic pain affecting the upper limbs. The investigators propose to investigate the effect of dorsal root stimulation in patients with chronic hand or upper limb pain.
Study details
- Official title
- An Observational Cohort Study to Assess the Long Term Effectiveness of Dorsal Root Ganglion Stimulation for Chronic Pain in the Upper Limb(s)
- Conditions
- Dorsal Root Ganglion Stimulation
- Pain in Limb, Hand, Foot, Fingers and Toes
- Causalgia of Upper Limb
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Collaborators
- Diakonessenhuis, Utrecht
- Start date
- 2015-09
- Primary completion
- 2017-01-01
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Netherlands
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
* Subject is appropriate for SCS implantation according to standard criteria from the Dutch Neuromodulation Society * Subject is \>18 to \<75 years old. * Subject is able and willing to comply with the follow-up schedule and protocol * Subject has chronic (\> 6 months) uni/bi-lateral pain, primarily in the upper limb(s) * (Arm and/or Hand) * Minimum baseline pain rating of 60 mm on the VAS in the primary region of pain * Documented, successful paraesthesia mapping of transient stimulation over painful anatomy * Subject is able to provide written informed consent Exclusion criteria * Subject has no other exclusion criteria for SCS implantation according to standard criteria from the Dutch Neuromodulation Society * Subject has had corticosteroid therapy at an intended site of stimulation within the past 30 days * Subject has had radiofrequency treatment of an intended target DRG within the past 3 months * Subject has participated in another clinical study within 30 days * Subject has been previously treated with and failed to respond to an implantable neuromodulation therapy * Subject has had a complete or partial amputation of the painful upper limb(s) and is experiencing phantom and/or stump pain post amputation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02553876